| Amgen to Buy Micromet for $1.16 Billion - New York Times |
|
|
New York Times By EVELYN M. RUSLI Axel Koester for The New York TimesCrescent Heights Dialysis Center in Los Angeles, like many of its counterparts, administers Amgen's drug Epogen. Amgen has agreed to buy Micromet, a biotechnology company that develops cancer drugs, |